Agarwal Banwari, Davenport Andrew
Banwari Agarwal, Intensive Care Unit, The Royal Free Hospital, NW32QG London, United Kingdom.
World J Hepatol. 2014 Oct 27;6(10):696-703. doi: 10.4254/wjh.v6.i10.696.
Renal function in patients with advanced cirrhosis is an important prognostic factor for survival both prior to and following liver transplantation. The importance of renal function is reflected by the introduction of the model for end stage liver disease (MELD) score, which includes serum creatinine. The MELD score has been shown to predict the short term risk of death for transplant wait listed patients and is currently used by many countries to allocate liver transplants on the basis of severity of underlying illness. Changes in serum creatinine are also used to stage acute kidney injury. However prior to liver transplantation the serum creatinine typically over estimates underlying renal function, particularly when a colorimetric Jaffe based assay is used, and paradoxically then under estimates renal function post liver transplantation, particularly when immunophyllins are started early as part of transplant immunosuppression. As acute kidney injury is defined by changes in serum creatinine, this potentially leads to over estimation of the incidence and severity of acute kidney injury in the immediate post-operative period.
晚期肝硬化患者的肾功能是肝移植前后生存的重要预后因素。终末期肝病模型(MELD)评分的引入体现了肾功能的重要性,该评分包括血清肌酐。MELD评分已被证明可预测等待移植患者的短期死亡风险,目前许多国家根据潜在疾病的严重程度使用该评分来分配肝移植。血清肌酐的变化也用于急性肾损伤的分期。然而,在肝移植前,血清肌酐通常会高估潜在肾功能,尤其是在使用基于比色法的Jaffe检测时;而在肝移植后,血清肌酐又会反常地低估肾功能,尤其是在早期开始使用免疫抑制剂作为移植免疫抑制的一部分时。由于急性肾损伤是由血清肌酐变化定义的,这可能导致术后早期急性肾损伤的发生率和严重程度被高估。